Pacific Biomarkers, Inc. Awarded Nine Contracts in Early 2011 for Studies in Immunogenicity, Diabetes and Other Areas

Share |

The nine contracts are in the areas of immunogenicity, tech transfers, diabetes, ADA, inflammatory and bone markers. The total Value of New Contracts is $920K

Seattle, WA (I-Newswire) April 27, 2011 - Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, has been awarded by one sponsor, nine contracts in early 2011 with a total value of approximately $920,000. The nine contracts are in the areas of immunogenicity, tech transfers, diabetes, ADA, inflammatory and bone markers. The work will take place in FY2011 to FY2014.

Sheri’ DuMond, PBI’s Director of Business Development, said, “These contracts are evidence of the importance and relevance of PBI’s services to the pharmaceutical and biotech research community. They show that our expertise is a valuable asset, and position us for further growth as we seek to expand our market presence.”

About Pacific Biomarkers, Inc. (PBI)
Established in 1989, PBI provides biomarker laboratory services and contract research services to support pharmaceutical and diagnostic manufacturers conducting human clinical trial research. The Company provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity, and nutrition. The PBI laboratory is accredited by the College of American Pathologists, New York State, and the Lipid Standardization Program. PBI's clients include many of the world's largest pharmaceutical, biotech, and diagnostic companies. PBI also provides clinical biomarker services focusing on the emerging field of biomarker assay development and testing. Services include validating and performing custom assays for novel clinical biomarkers, immunogenicity testing, mass spectrometry, and multiplex testing. PBI is headquartered in Seattle, Washington, and its common stock trades on the OTC Bulletin Board under the symbol "PBMC."

For more information about PBI, visit the company's website at www.pacbio.com.

About The Investor Relations Group:
A first-in-class online destination for investors, the public, and media interested in small-cap public companies.

Company Contact Information
The Investor Relations Group
Janet Vasquez
11 Stone Street 3rd floor
10004
Phone : 212-825-3210

Print Release

Share this News Release

Published in:

Medical > Pharmaceuticals

Tags:

biotechnology Laboratory labs biomarkers

Published on:

April 27, 2011

Content Disclaimer: If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service company and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter,make sure to check the official company website for accurate release dates as our site displays the date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for inaccuracies or omissions in that information or for actions taken in reliance on that information.

Related Releases

Odessa’s Healthy Heart Center Celebrates Ten Years of Helping Heart Patients Live Active, Symptom-Free Lives with the Assistance of Non-Invasive EECP® Therapy
Healthy Heart’s medical director, Dr. Suresh Gadasalli, says the painless treatment has reduced or eliminated angina pain, fatigue, and shortness of breath for hundreds of the center’s patients

Helping Men To Perform To Their Best Abilities
Michael S. Kaplan was presented with an award by the Nevada Family Practice Association as “Consultant of the Year” and Las Vegas Magazine as “Top Doctor”. See how he can help resolve your concerns.

Registration Open for 1st Cancer Cachexia Conference in Boston, MA on September 21-23, 2012
We are pleased to announce that registration is now open for the first Cancer Cachexia Conference entitled, “Cancer Cachexia: Molecular Mechanisms and Therapeutic Approaches” to be held in Boston, USA on September 21-23, 2012, co-hosted by The Oh

Boston Cosmetic Surgery Center Introduces ChestSculpt for Treatment of Gynecomastia
May 16, 2012 -- Marshfield, MA - (May 16, 2012)-- Edwin Ishoo, MD, a cosmetic surgeon in Marshfield and Brookline, Massachusetts area, is pleased to offer ChestSculpt, an innovative and advanced procedure for treatment of gynecomastia.

Great Wall Chinese Medicine Has Big Event of Diabetes
This is a phenomenal opportunity for the public to learn techniques for well-being and to learn the newest information on Diabetes Prevention from one of the top Diabetes Experts in the world, Dr. Wang who will only be in the United States for 10 day